Latest Security News

Octava Minerals has successfully completed the initial phase of its $1.5 million capital raise, positioning the company to advance exploration and due diligence at its promising Federation Copper-Zinc-Silver Project.

Prodigy Gold has successfully raised over $7 million through a combined entitlement offer and placement, with Plutus Prospecting increasing its voting power to 19.9%. The funds will fuel exploration and development in the prolific Tanami Gold Province.

Diatreme Resources has achieved a significant milestone with its Northern Silica Project awarded Major Project Status and a 278% upgrade in its Si2 Deposit resource, positioning the company for long-term growth in the critical minerals sector.

Ausmon Resources reports promising assay results from its Limestone Coast Project, revealing significant rare earth element concentrations that bolster its exploration prospects in South Australia.

Uvre Limited has secured a transformative portfolio of New Zealand gold projects, including the high-grade Waitekauri asset, backed by a $4 million capital raise and new board appointments. The company is gearing up for its maiden drilling campaign this September.

Altech Batteries confirms the safety and durability of its CERENERGY® sodium-nickel-chloride battery technology through rigorous testing, while its Silumina Anodes™ pilot plant in Germany achieves a 50% capacity increase. An independent DNV study endorses the technology’s promising future.

Orion Minerals reported significant cash outflows in its June 2025 quarter, with liquidity stretched and financing facilities nearly maxed out. The company is pursuing a $5.8 million capital raising to support ongoing operations following recent feasibility study completions.

Orion Minerals is advancing its Prieska Copper Zinc Mine towards production, targeting first concentrate by Christmas 2026, supported by a recent $5.8 million capital raise and ongoing project optimisation.

Alterity Therapeutics has secured U.S. FDA Fast Track designation for its drug ATH434 targeting Multiple System Atrophy, supported by promising Phase 2 clinical trial data showing slowed disease progression and a solid safety profile.

Austral Gold’s Q2 2025 report reveals a production decline at its flagship Guanaco Mine alongside rising costs, while refurbishment at its Casposo Plant advances on schedule for a second-half restart.

Magnis Energy Technologies progresses detailed engineering on its Nachu Graphite Project and moves to fast track US anode material production, while navigating ASX suspension and IM3NY bankruptcy fallout.

Income Asset Management has sold its term deposit broking business to Perpetual Corporate Trust, streamlining operations and securing significant cost savings while ensuring client continuity.